GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (HAM:CLS1) » Definitions » Beneish M-Score

McKesson Europe AG (HAM:CLS1) Beneish M-Score : 0.00 (As of Apr. 30, 2024)


View and export this data going back to 2006. Start your Free Trial

What is McKesson Europe AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for McKesson Europe AG's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of McKesson Europe AG was 0.00. The lowest was 0.00. And the median was 0.00.


McKesson Europe AG Beneish M-Score Historical Data

The historical data trend for McKesson Europe AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Beneish M-Score Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.76 -2.89 -3.01 -2.00 -3.83

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.76 -2.89 -3.01 -2.00 -3.83

Competitive Comparison of McKesson Europe AG's Beneish M-Score

For the Medical Distribution subindustry, McKesson Europe AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


McKesson Europe AG's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's Beneish M-Score falls into.



McKesson Europe AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of McKesson Europe AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4493+0.528 * 1.0205+0.404 * 0.6211+0.892 * 1.0868+0.115 * 0.3931
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8953+4.679 * -0.171145-0.327 * 0.7699
=-3.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar22) TTM:Last Year (Mar21) TTM:
Total Receivables was €924 Mil.
Revenue was €9,257 Mil.
Gross Profit was €804 Mil.
Total Current Assets was €4,150 Mil.
Total Assets was €5,102 Mil.
Property, Plant and Equipment(Net PPE) was €360 Mil.
Depreciation, Depletion and Amortization(DDA) was €160 Mil.
Selling, General, & Admin. Expense(SGA) was €22 Mil.
Total Current Liabilities was €2,278 Mil.
Long-Term Debt & Capital Lease Obligation was €152 Mil.
Net Income was €-872 Mil.
Gross Profit was €0 Mil.
Cash Flow from Operations was €1 Mil.
Total Receivables was €1,892 Mil.
Revenue was €8,518 Mil.
Gross Profit was €755 Mil.
Total Current Assets was €4,903 Mil.
Total Assets was €7,047 Mil.
Property, Plant and Equipment(Net PPE) was €827 Mil.
Depreciation, Depletion and Amortization(DDA) was €114 Mil.
Selling, General, & Admin. Expense(SGA) was €22 Mil.
Total Current Liabilities was €3,902 Mil.
Long-Term Debt & Capital Lease Obligation was €458 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(923.6 / 9257.1) / (1891.6 / 8517.7)
=0.099772 / 0.222079
=0.4493

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(754.8 / 8517.7) / (803.8 / 9257.1)
=0.088615 / 0.086831
=1.0205

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4150 + 359.6) / 5102.1) / (1 - (4902.6 + 827.1) / 7047.3)
=0.116129 / 0.186965
=0.6211

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=9257.1 / 8517.7
=1.0868

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(113.8 / (113.8 + 827.1)) / (159.8 / (159.8 + 359.6))
=0.120948 / 0.307663
=0.3931

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(21.7 / 9257.1) / (22.3 / 8517.7)
=0.002344 / 0.002618
=0.8953

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((152.4 + 2277.8) / 5102.1) / ((457.6 + 3902.3) / 7047.3)
=0.476314 / 0.618662
=0.7699

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-872.3 - 0 - 0.9) / 5102.1
=-0.171145

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

McKesson Europe AG has a M-score of -3.83 suggests that the company is unlikely to be a manipulator.


McKesson Europe AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (HAM:CLS1) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (HAM:CLS1) Headlines

No Headlines